share_log

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $50

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $50

HC Wainwright & Co.维持对Replimune Group的买入,将目标股价下调至50美元
Benzinga ·  2023/08/07 06:22

HC Wainwright & Co. analyst Robert Burns maintains Replimune Group (NASDAQ:REPL) with a Buy and lowers the price target from $51 to $50.

HC Wainwright&Co.分析师罗伯特·伯恩斯维持复制集团(纳斯达克股票代码:REPL)的买入,并将目标价从51美元下调至50美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发